183 related articles for article (PubMed ID: 25265428)
1. Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.
Adam AC; Scriba A; Ortmann M; Huss S; Kahl P; Steiner S; Störkel S; Büttner R
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):54-9. PubMed ID: 25265428
[TBL] [Abstract][Full Text] [Related]
2. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
3. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of amylase α-1A, MOC 31, and
Abouhashem NS; Abdelbary EH; H Abdalla MM; El-Shazly M
Indian J Pathol Microbiol; 2020; 63(3):405-411. PubMed ID: 32769329
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
[TBL] [Abstract][Full Text] [Related]
6. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
[TBL] [Abstract][Full Text] [Related]
7. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy for hybrid oncocytic/chromophobe renal cell tumors by exploiting an immunohistochemical and histochemical combined panel.
Roncati L; Barbolini G; Maiorana A
Diagnosis (Berl); 2017 Jun; 4(2):109-110. PubMed ID: 29536916
[No Abstract] [Full Text] [Related]
9. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
10. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
12. Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma.
Ohe C; Kuroda N; Takasu K; Senzaki H; Shikata N; Yamaguchi T; Miyasaka C; Nakano Y; Sakaida N; Uemura Y
Med Mol Morphol; 2012 Jun; 45(2):98-104. PubMed ID: 22718295
[TBL] [Abstract][Full Text] [Related]
13. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
14. FOXI1 Immunohistochemistry Differentiates Benign Renal Oncocytoma from Malignant Chromophobe Renal Cell Carcinoma.
Molnar A; Horvath CA; Czovek P; Szanto A; Kovacs G
Anticancer Res; 2019 Jun; 39(6):2785-2790. PubMed ID: 31177114
[TBL] [Abstract][Full Text] [Related]
15. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
An J; Park CK; Kim M; Joo JW; Cho NH
Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
[TBL] [Abstract][Full Text] [Related]
16. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
[TBL] [Abstract][Full Text] [Related]
18. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
Okoń K; Sińczak-Kuta A
Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
[TBL] [Abstract][Full Text] [Related]
20. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
